Screening for colorectal cancer: does it all start with aberrant crypt foci?

Gastrointestinal Endoscopy

Volumn 67, Issue 7, 2008, Pages 1103-1105

  Rasheed, Shaheen ^a   Rigas, Basil ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC;

ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PREVENTION; CANCER SCREENING; CARCINOGENESIS; CELL TRANSFORMATION; CHROMOENDOSCOPY; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CRYPT CELL; EDITORIAL; ENDOSCOPY; GENE MUTATION; GENOMIC INSTABILITY; HETEROZYGOSITY; HUMAN; METASTASIS; PRIORITY JOURNAL;

ADENOMA; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MASS SCREENING; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 44149101216     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.10.038     Document Type: Editorial

References (15)

1. American Cancer Society. Statistics for 2006 (2006), American Cancer Society, Atlanta
2. Leedham S.J., Thliveris A.T., Halberg R.B., et al. Gastrointestinal stem cells and cancer: bridging the molecular gap. Stem Cell Rev 1 (2005) 233-241
3. Bird R.P., and Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112-113 (2000) 395-402
4. Cheng L., and Lai M.D. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 9 (2003) 2642-2649
5. Alrawi S.J., Schiff M., Carroll R.E., et al. Aberrant crypt foci. Anticancer Res 26 (2006) 107-119
6. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37 (1987) 147-151
7. Roncucci L., Stamp D., Medline A., et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22 (1991) 287-294
8. Pretlow T.P., Barrow B.J., Ashton W.S., et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51 (1991) 1564-1567
9. Takayama T., Katsuki S., Takahashi Y., et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339 (1998) 1277-1284
10. Schoen R.E., Mutch M., Rall C., et al. The natural history of aberrant crypt foci. Gastrointest Endosc 67 (2008) 1097-1102
11. Siu I.M., Pretlow T.G., Amini S.B., et al. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 150 (1997) 1805-1813
12. Takayama T., Ohi M., Hayashi T., et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121 (2001) 599-611
13. Alrawi S.J., Carroll R.E., Hill H.C., et al. Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH. Mutat Res 601 (2006) 30-38
14. Takayama T., Miyanishi K., Hayashi T., et al. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness. Clin Gastroenterol Hepatol 3 Suppl 1 (2005) S42-S45
15. Williams W. The doctor stories (1984), New Directions Publishing, New York (NY) p. 84